Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The withdrawal of drugs for commercial reasons: the incomplete story of tositumomab.

× No keyword cloud information.

8 in total

1. The race for drug approvals: hasten slowly?

Authors: Alain Braillon
Journal: Eur J Clin Pharmacol Date: 2018-05-22 Impact factor: 2.953

Review 2. The evolving role of targeted biological agents in the management of indolent B-cell lymphomas.

Authors: Trent Peng Wang; John Harwood Scott; Stefan Klaus Barta
Journal: Ther Adv Hematol Date: 2017-11-22

3. Association of rituximab with graphene oxide confers direct cytotoxicity for CD20-positive lymphoma cells.

Authors: Chengke Luo; Zhenghao Deng; Lan Li; Frederic Clayton; Alexander L Chen; Ran Wei; Rodney Miles; Deborah M Stephens; Martha Glenn; Xiyang Wang; Peter E Jensen; Xinjian Chen
Journal: Oncotarget Date: 2016-03-15

Review 4. Combination Radioimmunotherapy Approaches and Quantification of Immuno-PET.

Authors: Jin Su Kim
Journal: Nucl Med Mol Imaging Date: 2016-01-26

Review 5. New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.

Authors: Isabel Corraliza-Gorjón; Beatriz Somovilla-Crespo; Silvia Santamaria; Jose A Garcia-Sanz; Leonor Kremer
Journal: Front Immunol Date: 2017-12-21 Impact factor: 7.561

6. Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate ¹⁷⁷Lu-NNV003.

Authors: Astri Fjelde Maaland; Helen Heyerdahl; Adam O'Shea; Bergthora Eiriksdottir; Véronique Pascal; Jan Terje Andersen; Arne Kolstad; Jostein Dahle
Journal: Eur J Nucl Med Mol Imaging Date: 2019-07-15 Impact factor: 9.236

7. Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20⁺ B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis.

Authors: Chengxin Luo; Guixian Wu; Xiangtao Huang; Yanni Ma; Yali Zhang; Qiuyue Song; Mingling Xie; Yanni Sun; Yarui Huang; Zhen Huang; Yu Hou; Shuangnian Xu; Jieping Chen; Xi Li
Journal: Sci Rep Date: 2021-02-05 Impact factor: 4.379

Review 8. Radioimmunotherapy-based conditioning regimen prior to autologous stem cell transplantation in non-Hodgkin lymphoma.

Authors: Mahsa Eskian; MirHojjat Khorasanizadeh; Alessandro Isidori; Nima Rezaei
Journal: Int J Hematol Oncol Date: 2018-06-13